We are happy to welcome in our cluster Proteona -pioneering the use of single cell proteogenomics to improve clinical outcomes.
Proteona is a new biomedical company based in Singapore, the US, and Germany, that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR).
The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.
We are looking forward to see your active participation in the network!
You can find here more information about Proteona.